PX-478, the lead in a novel class of HIF-1 inhibitors with excellent antitumor activity Nov. 26, 2002
Specific, orally available ETA receptor antagonist reported to have potential in cancer Nov. 25, 2002
Korean researchers select novel HDAC inhibitor for further evaluation as potential cancer therapy Nov. 25, 2002
RSS